Amalgent Therapeutics, LLC

Pharmaceutical company · Chapel Hill, North Carolina, United States

Amalgent Therapeutics, LLC is a pharmaceutical company headquartered in Chapel Hill, North Carolina, United States. Its earliest recorded incorporation is in 2020. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.8 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $200,000 sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Amalgent Therapeutics at a glance

Typepharmaceutical company
HeadquartersChapel Hill, North Carolina, United States
Earliest incorporation on record2020
Employees (self-reported, 2024)2
SEC CIK1924038

What does Amalgent Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $2.8 million in total (2023 to 2024). NIH funding came from the National Institute on Drug Abuse.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $200,000 sold (2022).

Frequently asked questions about Amalgent Therapeutics

Where is Amalgent Therapeutics headquartered?

Amalgent Therapeutics, LLC is headquartered in Chapel Hill, North Carolina, United States.

What does Amalgent Therapeutics do?

Amalgent Therapeutics, LLC is a pharmaceutical company.

When was Amalgent Therapeutics founded?

The earliest incorporation on record for Amalgent Therapeutics, LLC is in 2020, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences